Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 3, Pages 453-462
Publisher
American Society of Hematology
Online
2014-06-03
DOI
10.1182/blood-2014-04-567933
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
- (2014) S. D. Brown et al. GENOME RESEARCH
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer
- (2013) Anneke Neumann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
- (2013) Dan A. Landau et al. CELL
- Lessons from the Cancer Genome
- (2013) Levi A. Garraway et al. CELL
- HLA ligandome tumor antigen discovery for personalized vaccine approach
- (2013) Hans-Georg Rammensee et al. Expert Review of Vaccines
- Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
- (2013) Ute E. Burkhardt et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
- (2013) Y.-C. Lu et al. JOURNAL OF IMMUNOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Getting Personal with Neoantigen-Based Therapeutic Cancer Vaccines
- (2013) N. Hacohen et al. Cancer Immunology Research
- Targeting the Epidermal Growth Factor Receptor in Solid Tumor Malignancies
- (2012) Mette K. Nedergaard et al. BIODRUGS
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogeneFNDC3B
- (2012) Chunlin Cai et al. CELL CYCLE
- Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients
- (2012) A. Cai et al. CLINICAL CANCER RESEARCH
- The cancer antigenome
- (2012) Bianca Heemskerk et al. EMBO JOURNAL
- Re: Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients with Renal Cell Carcinoma
- (2012) Samir S. Taneja JOURNAL OF UROLOGY
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
- (2012) Hirokazu Matsushita et al. NATURE
- Expression of tumour-specific antigens underlies cancer immunoediting
- (2012) Michel DuPage et al. NATURE
- Absolute quantification of somatic DNA alterations in human cancer
- (2012) Scott L Carter et al. NATURE BIOTECHNOLOGY
- Tumor Heterogeneity and Personalized Medicine
- (2012) Dan L. Longo NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Many Tumors in One: A Daunting Therapeutic Prospect
- (2011) Chibawanye I. Ene et al. CANCER CELL
- Therapeutic vaccination against human papilloma virus induced malignancies
- (2011) Sjoerd H van der Burg et al. CURRENT OPINION IN IMMUNOLOGY
- Machine learning competition in immunology – Prediction of HLA class I binding peptides
- (2011) Guang Lan Zhang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cloning of a Novel Protein Interacting with BRS-3 and Its Effects in Wound Repair of Bronchial Epithelial Cells
- (2011) Hui Jun Liu et al. PLoS One
- Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Prediction of epitopes using neural network based methods
- (2010) Claus Lundegaard et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases
- (2009) I. Del Giudice et al. BLOOD
- HLA ligand profiles of primary renal cell carcinoma maintained in metastases
- (2009) Juliane Sarah Stickel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia
- (2009) T. Nishida et al. CLINICAL CANCER RESEARCH
- COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
- (2009) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
- (2008) Hong Lin et al. BMC IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now